Investor insights
Sectors invested in
biodegradable2
Manufacturing2
Genetics2
Biotechnology2
bioplastics2
PHA2
sustainable solutions2
synthetic biology2
biotechnology2
Funding rounds participated in
$33M sweet spot round size
Most of their 2 investments are in rounds between $13M and $53M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Immunotherapy Targets
Elite Antibody
Growth Factors
Recombinant Antibody Production
Monoclonal Antibodies
Premium Cytokines
Viral Antigens
Covid-19 Reagents
Recombinant Protein
Gene/cDNA
Health Care
CRO Service
ProVir Viral Antigen Collection
Therapeutics
ELISA kits
Biotechnology tools and solutions
Recombinant Production Services
Date founded
2007
Investments made
P
PhaBuilder raised $53M on February 2, 2023
Investors: 上海自贸区股权投资基金管理有限公司, 北京中海投资, Sequoia Capital China and Sino Biological, Inc.
P
PhaBuilder raised $13M on November 4, 2022
Investors: Sino Biological, Inc.
Funding rounds raised
Total raised
$29M
from 2 investors over 2 rounds
S
Sino Biological, Inc. raised $16M on May 1, 2018
Investors: Qiming Venture Partners
S
Sino Biological, Inc. raised $29M on July 7, 2017
Investors: Qiming Venture Partners